NCT05180474 2026-04-13GEN1047 for Solid Tumors - First in Human (FIH) TrialGenmabPhase 1/2 Terminated179 enrolled
NCT07000344 2026-04-09A Study of Apatinib Combined With Letrozole With or Without Fluzoparib in Estrogen Receptor-Positive, Platinum-Sensitive Recurrent Ovarian Cancer Previously Treated With First-Line PARP InhibitorPeking Union Medical College HospitalPhase NA Terminated5 enrolled
NCT07035067 2026-04-07Multidimensional Burden of Platinum Resistant Ovarian Cancer (PROC) on Patients and Caregivers in CanadaPeriPharmTerminated24 enrolled
NCT04931823 2026-04-03Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid TumorsConjupro Biotherapeutics, Inc.Phase 1 Terminated34 enrolled
NCT04234113 2026-03-27Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid TumorsSotio Biotech Inc.Phase 1 Terminated115 enrolled 43 charts